RecruitingPhase 2NCT03866668

A Study of Esomeprazole in Children With Autism

Studying Interatrial communication

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Antonio Hardan, MD
Stanford University
Intervention
Esomeprazole(drug)
Enrollment
25 target
Eligibility
2-6 years · All sexes
Timeline
20192028

Study locations (1)

Collaborators

SPARK (Stanford University)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03866668 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication

← Back to all trials